Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin, Probiotic and N-acetylcysteine as Adjuncts to Standard Therapy for Helicobacter pylori Eradication
IRCT20220406054431N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of simvastatin and acetylcysteine in Helicobacter pylori infection, sponsored by Shahid Beheshti University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
simvastatinacetylcysteine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20220406054431N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220406054431N1.